Login
Toggle navigation
Videos
Categories
Trending
Pasqualino Monti Honored at CEO for LIFE Awards 2023 | Pasqualino Monti - CEO of ENAV
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Long Run is the main focus to Investing firm |Brooks G. Gordon, Managing Director, W. P. Carey & Co. LLC
00:10:00
Kevin Mahn, president & CIO of Hennion & Walsh, and Omar Aguilar, CEO of Schwab Asset Management, discuss market insights on "Closing Bell Overtime."
00:10:00
The Breakfast Show features discussions with Kjerstin Braathen, CEO of DNB, and Ziv Cohen, CEO of Paygilant.|Kjerstin Braathen, CEO of DNB
00:10:00
Ville Kangasmuukko on Bubbleroom's IPO Plans and E-commerce Strategy | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.
00:10:00
Tim Van Hauwermeiren, CEO of argenx, advocates for innovation and patient-centric approaches in developing breakthrough therapies.
00:10:00
Mithril Resources: Unveiling Promising Gold Discoveries in Serbia
00:10:00
We believe the key to treating neurodegenerative disease is to intervene early|David Kalergis,CEO,Diffusion Pharmaceuticals Inc
00:10:00
Melior Resources: Restarting Gunda Mine with Secure Funding and Offtake Agreements
00:10:00
Astronics showcases LiFi technology for aircraft in-flight entertainment content.|Peter J. Gundermann is Chairman, President and Chief Executive Officer of Astronics Corp
00:10:00
Scandium International: Leading the Way with the World's First Scandium Mine in Australia
00:10:00
Remon Vos on Yield Trends in Hungary and Romania | Remon Vos, President, CTP NV.
00:10:00
Preparing to Sell: Essential Advice for Business Owners - Sean Sebold | Founder and President, Sebold Capital Management - Nick Niemi | Financial Planner, Sebold Capital Management